Cargando…

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma

Tumor-initiating cells (TIC) are dynamic cancer cell subsets that display enhanced tumor functions and resilience to treatment but the mechanism of TIC induction or maintenance in lung cancer is not fully understood. In this study, we show the calcium pathway transcription factor NFATc2 is a novel r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zhi-Jie, Liu, Jing, Wang, Si-Qi, Zhu, Yun, Gao, Xu-Yuan, Tin, Vicky Pui-Chi, Qin, Jing, Wang, Jun-Wen, Wong, Maria Pik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570574/ https://www.ncbi.nlm.nih.gov/pubmed/28737489 http://dx.doi.org/10.7554/eLife.26733

Ejemplares similares

NFATC1 and NFATC2 expression patterns in human osteochondromas
por: Wang, Yuanyuan, et al.
Publicado: (2023)

CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation
por: Wang, Si-Qi, et al.
Publicado: (2020)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

DYRK1A activates NFATC1 to increase glioblastoma migration
por: Liu, Heng, et al.
Publicado: (2021)

EWSR1-NFATC2 and FUS-NFATC2 Gene Fusion-Associated Mesenchymal Tumors: Clinicopathologic Correlation and Literature Review
por: Bode-Lesniewska, Beata, et al.
Publicado: (2019)

NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation
por: Hessmann, Elisabeth, et al.
Publicado: (2016)

Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation
por: Perotti, V., et al.
Publicado: (2019)

An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
por: Perotti, Valentina, et al.
Publicado: (2019)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Regulation of NFATc1 in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2014)

RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
por: Kubota, Hirohito, et al.
Publicado: (2021)

Recent knowledge of NFATc4 in oncogenesis and cancer prognosis
por: Zhong, Qiu-Hua, et al.
Publicado: (2022)

Signal transduction studies on single cell level: P38, but not NFATc2, is the main regulator of NFATc1/A expression in human Th cells
por: Bendfeldt, H, et al.
Publicado: (2009)

Role of nuclear factor of activated T cells 2 (NFATc2) in allergic asthma
por: Jakobi, Marielena, et al.
Publicado: (2020)

Regulation of the Growth of Multinucleated Muscle Cells by an Nfatc2-Dependent Pathway
por: Horsley, Valerie, et al.
Publicado: (2001)

The Role of Ca(2+)-NFATc1 Signaling and Its Modulation on Osteoclastogenesis
por: Kang, Jung Yun, et al.
Publicado: (2020)

Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer
por: Patil, Shilpa, et al.
Publicado: (2021)

Macrophage NFATC2 mediates angiogenic signaling during mycobacterial infection
por: Brewer, W. Jared, et al.
Publicado: (2022)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
por: Park, Kyeong‐Lok, et al.
Publicado: (2018)

NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4(+) T lymphocytes by CD4(+) CD25(+) regulatory T cells
por: Bopp, Tobias, et al.
Publicado: (2005)

Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis
por: Jia, Yewei, et al.
Publicado: (2019)

Rhein-attenuates LPS-induced acute lung injury via targeting NFATc1/Trem2 axis
por: Li, Xiang, et al.
Publicado: (2023)

NFATc1 self-promotes to build bone
por: Van Epps, Heather L.
Publicado: (2005)

Architecture and Expression of the Nfatc1 Gene in Lymphocytes
por: Rudolf, Ronald, et al.
Publicado: (2014)

Association of Myocardial Changes and Gene Expression of the NFATC1 and NFATC4—Calcineurin Signaling Pathway in Children with Bicuspid Aortic Valve
por: Kamenshchyk, Andrii, et al.
Publicado: (2023)

RANK promotes colorectal cancer migration and invasion by activating the Ca(2+)-calcineurin/NFATC1-ACP5 axis
por: Liang, Qian, et al.
Publicado: (2021)

Induction of NFATc2 Expression by Interleukin 6 Promotes T Helper Type 2 Differentiation
por: Diehl, Sean, et al.
Publicado: (2002)

NFATC2 is a novel therapeutic target for colorectal cancer stem cells
por: Lang, Tingyuan, et al.
Publicado: (2018)

E-Cadherin, NFATC3, and PLP2 Are Differentially Methylated in Multiple Cancers
por: Lotesto, Mary J, et al.
Publicado: (2020)

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
por: Gouda, Mohamed A., et al.
Publicado: (2023)

The role of NPY2R/NFATc1/DYRK1A regulatory axis in sebaceous glands for sebum synthesis
por: Yang, Tao, et al.
Publicado: (2023)

Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels
por: Huang, Jing, et al.
Publicado: (2021)

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection
por: Romero-Masters, James C., et al.
Publicado: (2020)

Babam2 negatively regulates osteoclastogenesis by interacting with Hey1 to inhibit Nfatc1 transcription
por: Jin, Fujun, et al.
Publicado: (2022)

Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca(2+)/Calcineurin/p-NFATc3 Pathway
por: Wang, Xin, et al.
Publicado: (2021)

Atypical behavior of NFATc1 in cultured intercostal myofibers
por: Robison, Patrick, et al.
Publicado: (2014)

NFATc1 controls the cytotoxicity of CD8(+) T cells
por: Klein-Hessling, Stefan, et al.
Publicado: (2017)

Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity
por: Xiao, Yin, et al.
Publicado: (2020)

NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma
por: Murti, Krisna, et al.
Publicado: (2021)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
por: Xu, Sanrong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3k4trhhfnmu75cqifrqebbkiqf